Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications drug utilization physician survey intron a® europe
… Multi-Criteria Decision Analysis Most drug development and commercialization choices are complex. When you have multiple factors influencing a decision and you have to consider tradeoffs, you need a … Market Access and Post-Approval Decisions From making drug development decisions, to phase III evidence plans, to …
… William Paterson University, Wayne, NJ Andrew Pratt is a Data Manager with the Surveys and Observational Studies group at RTI-HS. As a member of the data management team, he has become … patient-reported outcome components in the US, Canada, and Europe, primarily in oncology and neurosciences. Additional …
… closed on its acquisition of Medical Data Analytics (MDA), a provider of real-world evidence (RWE) generation to the … MDA’s capabilities in data collection and management, and physician and site recruitment. “This acquisition fits … generation of clinical and economic evidence.” MDA employs a scientific, rigorous, and efficient method of data …
… and Marco Boeri of RTI Health Solutions have published a study in The Patient – Patient-Centered Outcomes Research … subject by addressing the question, “Does the choice of a respondent’s device adversely affect choice behavior or … attention Respondents’ self-reported understanding of the survey Failure rate of an internal validity test …
… before gaining regulatory approval by the US Food and Drug Administration to benefit eventual market access. Since … the inclusion of clinical data affect planned or pending publications? Manufacturers should determine the appropriate … and evidence tables). Takeaway 4: Provide patient utilization projections While early dossiers will not …
… Ophthalmology A Wealth of Experience We have collaborated with our clients … models (cost effectiveness, budget impact) Drug utilization studies Economic burden of illness studies …
… Economics Pomona College, Claremont, CA Rachel Weinrib is a Research Epidemiologist/Project Manager within the … teams and expertise in reproductive health epidemiology, drug utilization studies, vaccine safety, and external comparator …
… of Epidemiology at RTI Health Solutions has been named a fellow of the International Society for … in the field of pharmacoepidemiology. His experience and publications span many therapeutic areas, including kidney … lecturer on observational study design, large database utilization, and propensity score analysis. Read more about …
Navigating EU Joint Clinical Assessments and Joint Scientific Consultations From January 2025 Onward
… of the health technology assessment (HTA) process on a European level. Non-clinical HTA domains, which mainly … decision-makers also retain the final appraisal of a medicine and its recommendation for reimbursement for … plan. The ultimate success of JCAs and market access in Europe will increasingly hinge on including key …
… RTI-HS Webinar - Lessons Learned From a Review of FDA PRO Labeling Share on: December 12, 2016 … decade has seen an increased focus on patient-centered drug development. Product labeling based on patient-reported … (PRO) endpoints are therefore of special interest to drug manufacturers. The Patient-Centered Outcomes Assessment …